Search Results - "Alqarni, Abdullah A"

Refine Results
  1. 1

    Increased Thromboxane A2 Levels in Pulmonary Artery Smooth Muscle Cells Isolated from Patients with Chronic Obstructive Pulmonary Disease by Alqarni, Abdullah A.

    Published in Medicina (Kaunas, Lithuania) (13-01-2023)
    “…Introduction: Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 pulmonary hypertension, with no current…”
    Get full text
    Journal Article
  2. 2

    Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation by Alqarni, Abdullah A, Brand, Oliver J, Pasini, Alice, Alahmari, Mushabbab, Alghamdi, Abdulrhman, Pang, Linhua

    Published in Respiratory research (28-05-2022)
    “…Pulmonary hypertension is a common and serious complication of chronic obstructive pulmonary disease (COPD). Studies suggest that cigarette smoke can initiate…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Asthma medication adherence, control, and psychological symptoms: a cross-sectional study by Alqarni, Abdullah A, Aldhahir, Abdulelah M, Siraj, Rayan A, Alqahtani, Jaber S, Alghamdi, Dana A, Alghamdi, Sarah K, Alamoudi, Abeer A, Mohtaseb, Majduleen A, Majrshi, Mansour, AlGarni, Abdulkareem A, Badr, Omaima I, Alwafi, Hassan

    Published in BMC pulmonary medicine (19-04-2024)
    “…Nonadherence to therapies and psychological disorders are associated with poor asthma control. This study aims to assess the prevalence of anxiety and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Healthcare Providers’ Perception and Barriers Concerning the Use of Telehealth Applications in Saudi Arabia: A Cross-Sectional Study by Alghamdi, Saeed M, Aldhahir, Abdulelah M, Alqahtani, Jaber S, Siraj, Rayan A, Alsulayyim, Abdullah S, Almojaibel, Abdullah A, Alhotye, Munyra, Alanazi, Abdullah M, Alqarni, Abdullah A

    Published in Healthcare (Basel) (01-08-2022)
    “…Background: Telehealth services are widely used in Saudi Arabia. Despite this, neither the use rate nor the attitudes, perceptions, and barriers concerning…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD by Alqarni, Abdullah A., Aldhahir, Abdulelah M., Alghamdi, Sara A., Alqahtani, Jaber S., Siraj, Rayan A., Alwafi, Hassan, AlGarni, Abdulkareem A., Majrshi, Mansour S., Alshehri, Saad M., Pang, Linhua

    Published in Frontiers in medicine (10-10-2023)
    “…Pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 PH, with no current proven targeted therapies. Studies…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review by Alqarni, Abdullah A., Aldhahir, Abdulelah M., Bintalib, Heba M., Alqahtani, Jaber S., Siraj, Rayan A., Majrshi, Mansour, AlGarni, Abdulkareem A., Naser, Abdallah Y., Alghamdi, Sara A., Alwafi, Hassan

    Published in Frontiers in medicine (29-08-2023)
    “…Background Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) is classified as group 3 pulmonary…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Spirometry profiles of overweight and obese individuals with unexplained dyspnea in Saudi Arabia by Alqarni, Abdullah A., Aldhahir, Abdulelah M., Alqahtani, Jaber S., Siraj, Rayan A., Aldhahri, Joud H., Madkhli, Shahad A., Fares, Wanas M., Alqurayqiri, Abeer A., Alyami, Mohammed M., Naser, Abdallah Y., Alwafi, Hassan

    Published in Heliyon (15-02-2024)
    “…Obesity is a common cause of dyspnea. However, the impacts of obesity on spirometry parameters, particularly among individuals with unexplained dyspnea, have…”
    Get full text
    Journal Article
  19. 19
  20. 20